ABBV

AbbVie Inc. (ABBV)

Last Price$202.10.6%
Market Cap$356.7B
LTM ROIC - WACC
1.8%
5Y avg
7.9%
Drug Manufacturers - General industry median
6.1%
Stock quality & Intrinsic value
6/10
0.2% undervalued

AbbVie Inc. ROIC - WACC

Annual
Quarterly
LTM
Industry median
Company stand-alone
ABBV
Healthcare
Crunching data... Almost there!
Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
ROIC - WACC
0.0%
19.9%
16.1%
34.5%
23.4%
14.7%
18.3%
11.8%
9.2%
7.4%
24.5%
8.3%
9.2%
7.9%
4.3%
ABBV
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for ABBV and see if it's the right time to invest.
Dive in

AbbVie Inc. (ABBV) ROIC - WACC comparison analysis

Crunching data... Almost there!

ABBV key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is AbbVie Inc.'s ROIC - WACC?

As of today, Microsoft Corp's last 12-month ROIC - WACC is 1.8%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual ROIC - WACC for AbbVie Inc. have been 6.2% over the past three years, and 8.3% over the past five years.

2) Is AbbVie Inc.'s ROIC - WACC Good?

As of today, AbbVie Inc.'s ROIC - WACC is 1.8%, which is lower than industry median of 6.1%. It indicates that AbbVie Inc.'s ROIC - WACC is Bad.

3) How does AbbVie Inc.'s ROIC - WACC compare to its peers?

As of today, AbbVie Inc.'s ROIC - WACC is 1.8%, which is lower than peer median of 8.0%. The list of peers includes LLY, MRK, GILD, NVS, PFE, BMY, AMGN, JNJ, SNY, AZN.